Immunomodulation Therapies for Atherosclerosis: The Past, the Present, and the Future.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
01 Jul 2023
Historique:
received: 28 05 2023
revised: 26 06 2023
accepted: 30 06 2023
medline: 17 7 2023
pubmed: 14 7 2023
entrez: 14 7 2023
Statut: epublish

Résumé

Atherosclerotic cardiovascular disease is the most common cause of morbidity and death worldwide. Recent studies have demonstrated that this chronic inflammatory disease of the arterial wall can be controlled through the modulation of immune system activity. Many patients with cardiovascular disease remain at elevated risk of recurrent events despite receiving current, state-of-the-art preventive medical treatment. Much of this residual risk is attributed to inflammation. Therefore, finding new treatment strategies for this category of patients became of common interest. This review will discuss the experimental and clinical data supporting the possibility of developing immune-based therapies for lowering cardiovascular risk, explicitly focusing on vaccination strategies.

Identifiants

pubmed: 37446157
pii: ijms241310979
doi: 10.3390/ijms241310979
pmc: PMC10342012
pii:
doi:

Substances chimiques

Autoantigens 0
Vaccines 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Heart. 2015 Nov;101(21):1738-47
pubmed: 26310262
J Nucl Med. 2007 Nov;48(11):1800-15
pubmed: 17942804
N Engl J Med. 2019 Dec 26;381(26):2497-2505
pubmed: 31733140
Arterioscler Thromb Vasc Biol. 2010 May;30(5):946-52
pubmed: 20167655
J Am Heart Assoc. 2020 Mar 3;9(5):e014941
pubmed: 32122219
PLoS One. 2018 Feb 13;13(2):e0191895
pubmed: 29438441
Nature. 2010 Apr 29;464(7293):1357-61
pubmed: 20428172
Arterioscler Thromb. 1992 Apr;12(4):461-7
pubmed: 1558837
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):872-8
pubmed: 12649091
J Clin Invest. 1999 Mar;103(6):773-8
pubmed: 10079097
Circ Res. 2017 Feb 17;120(4):617-619
pubmed: 28209792
J Am Coll Cardiol. 2021 Apr 20;77(15):1845-1855
pubmed: 33858620
Immunity. 2011 Aug 26;35(2):161-8
pubmed: 21867926
J Atheroscler Thromb. 2021 Oct 1;28(10):1025-1034
pubmed: 33191364
Eur Heart J. 2008 Sep;29(18):2218-26
pubmed: 18664466
Physiol Rev. 2006 Apr;86(2):515-81
pubmed: 16601268
Cells. 2020 Dec 11;9(12):
pubmed: 33322482
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):605-12
pubmed: 22223728
Arterioscler Thromb Vasc Biol. 2003 Jun 1;23(6):1060-5
pubmed: 12702515
Nat Rev Immunol. 2016 Aug;16(8):485-97
pubmed: 27346802
Antioxid Redox Signal. 2010 Jul 1;13(1):39-75
pubmed: 19888833
J Am Heart Assoc. 2017 Jul 15;6(7):
pubmed: 28711866
J Am Coll Cardiol. 1997 Dec;30(7):1886-91
pubmed: 9385923
Autoimmunity. 2005 Mar;38(2):171-9
pubmed: 16040338
Atherosclerosis. 2019 Apr;283:69-78
pubmed: 30797988
Nat Rev Cardiol. 2020 Jul;17(7):387-401
pubmed: 32203286
J Intern Med. 2008 Dec;264(6):563-70
pubmed: 18783480
Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1120-6
pubmed: 23640492
Circulation. 2017 Nov 14;136(20):1875-1877
pubmed: 28916641
Curr Opin Immunol. 2003 Oct;15(5):522-7
pubmed: 14499260
Nat Med. 2019 Oct;25(10):1576-1588
pubmed: 31591603
Arterioscler Thromb Vasc Biol. 2016 Apr;36(4):765-71
pubmed: 26916732
Circulation. 2004 Oct 5;110(14):2047-52
pubmed: 15451805
Cardiovasc Res. 2019 Jan 1;115(1):213-221
pubmed: 30052808
Int J Cardiol. 2014 Oct 20;176(3):710-7
pubmed: 25131923
Front Immunol. 2013 Dec 27;4:493
pubmed: 24416033
J Intern Med. 2008 May;263(5):464-78
pubmed: 18410590
J Clin Invest. 1999 Jan;103(1):117-28
pubmed: 9884341
J Exp Med. 2004 Apr 19;199(8):1121-31
pubmed: 15096538
Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):1119-27
pubmed: 15802622
Atherosclerosis. 2017 Dec;267:127-138
pubmed: 29126031
Annu Rev Immunol. 2004;22:361-403
pubmed: 15032582
Atherosclerosis. 2022 Apr;346:68-74
pubmed: 35290813
J Intern Med. 2011 May;269(5):546-56
pubmed: 21114693
J Am Coll Cardiol. 2014 Dec 30;64(25):2779-91
pubmed: 25541132
Science. 2017 Feb 24;355(6327):842-847
pubmed: 28104796
N Engl J Med. 2020 Nov 5;383(19):1838-1847
pubmed: 32865380
N Engl J Med. 2017 May 4;376(18):1713-1722
pubmed: 28304224
JACC Cardiovasc Imaging. 2015 Apr;8(4):493-494
pubmed: 25457756
Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):1074-9
pubmed: 8696949
Proc Natl Acad Sci U S A. 1989 Feb;86(4):1372-6
pubmed: 2465552
Nature. 2018 Jun;558(7709):301-306
pubmed: 29875409
N Engl J Med. 2017 Sep 21;377(12):1119-1131
pubmed: 28845751
J Cardiovasc Dev Dis. 2021 Oct 10;8(10):
pubmed: 34677199
Sci Rep. 2021 Apr 27;11(1):9022
pubmed: 33907226
Eur Heart J. 2016 Aug 07;37(30):2406-13
pubmed: 27161611
Am Heart J. 2016 Jul;177:58-65
pubmed: 27297850
Nat Med. 2003 Jun;9(6):736-43
pubmed: 12740573
J Immunol. 2010 Oct 1;185(7):4410-9
pubmed: 20817865
Atherosclerosis. 2003 Jul;169(1):113-20
pubmed: 12860257
Arterioscler Thromb Vasc Biol. 2018 May;38(5):e71-e84
pubmed: 29599140
N Engl J Med. 1989 Apr 6;320(14):915-24
pubmed: 2648148
PLoS One. 2012;7(2):e30780
pubmed: 22347402
Nat Rev Cardiol. 2019 Jul;16(7):389-406
pubmed: 30846875
J Clin Invest. 1995 Jun;95(6):2611-9
pubmed: 7769103
Proc Natl Acad Sci U S A. 1995 Jan 31;92(3):821-5
pubmed: 7846059
J Am Coll Cardiol. 2005 May 17;45(10):1585-93
pubmed: 15893171
Nat Rev Cardiol. 2019 Mar;16(3):180-196
pubmed: 30410107
Am J Pathol. 1989 Jul;135(1):169-75
pubmed: 2505620
Cardiovasc Res. 2006 Jul 15;71(2):259-68
pubmed: 16580654
J Vasc Surg. 2016 Jan;63(1):133-41.e1
pubmed: 26433546
Proc Natl Acad Sci U S A. 1995 Apr 25;92(9):3893-7
pubmed: 7732003
J Am Coll Cardiol. 2014 Aug 5;64(5):485-94
pubmed: 25082583

Auteurs

Dalgisio Lecis (D)

Division of Cardiology, "Tor Vergata" University Hospital, Viale Oxford 81, 00133 Rome, Italy.

Gianluca Massaro (G)

Division of Cardiology, "Tor Vergata" University Hospital, Viale Oxford 81, 00133 Rome, Italy.

Daniela Benedetto (D)

Division of Cardiology, "Tor Vergata" University Hospital, Viale Oxford 81, 00133 Rome, Italy.

Marco Di Luozzo (M)

Division of Cardiology, "Tor Vergata" University Hospital, Viale Oxford 81, 00133 Rome, Italy.

Giulio Russo (G)

Division of Cardiology, "Tor Vergata" University Hospital, Viale Oxford 81, 00133 Rome, Italy.

Alessandro Mauriello (A)

Department of Experimental Medicine, University "Tor Vergata", 00133 Rome, Italy.

Massimo Federici (M)

Department of Systemic Medicine, University "Tor Vergata", 00133 Rome, Italy.

Giuseppe Massimo Sangiorgi (GM)

Division of Cardiology, "Tor Vergata" University Hospital, Viale Oxford 81, 00133 Rome, Italy.
Department of Biomedicine and Prevention, "Tor Vergata" University of Rome, 00133 Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH